Study Summary
This trial is a prospective, single center, interventional study evaluating the safety and efficacy of SCT in patients with BCAS.
- Lung Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: Measurement intervals: 2 weeks pre-procedure, 2 weeks post procedure, 3 months and then 6 months post intervention.
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Intervention
1 of 2
Control
1 of 2
Active Control
Non-Treatment Group
40 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants has the maximum capacity of this experiment been set to?
"Affirmative. According to clinicaltrials.gov, this experiment is currently accepting participants. It was originally posted on October 25th 2021 and has since been edited on March 18th 2022. 40 individuals are needed from one site for the study's completion." - Anonymous Online Contributor
Is there an open enrollment period for this research endeavor?
"Per clinicaltrials.gov, this study is actively recruiting patients and was initially posted on October 25th 2021 with the most recent edit occurring on March 18th 2022." - Anonymous Online Contributor